MoneyWorks4Me

An increase of about 336.32% to Rs. 235.22 millions in the total revenue was observed for the quarter ended June 2026. The total revenue was pegged at Rs. 53.91 millions during the similar quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 1360.64% from Rs. 10.29 millions to Rs. 150.30  millions.OP of the company witnessed a marginal growth to 217.46 millions from 24.28 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 235.22 53.91 336.32 235.22 53.91 336.32 567.06 325.87 74.01
Other Income 5.40 11.10 -51.35 5.40 11.10 -51.35 45.85 42.07 8.99
PBIDT 217.46 24.28 795.63 217.46 24.28 795.63 333.09 169.36 96.68
Interest 4.30 2.68 60.45 4.30 2.68 60.45 10.93 5.95 83.70
PBDT 213.16 21.60 886.85 213.16 21.60 886.85 322.16 163.41 97.15
Depreciation 10.74 7.87 36.47 10.74 7.87 36.47 34.43 30.05 14.58
PBT 202.42 13.73 1374.29 202.42 13.73 1374.29 287.73 133.36 115.75
TAX 52.12 3.44 1415.12 52.12 3.44 1415.12 67.26 37.62 78.79
Deferred Tax 0.44 -0.62 -170.97 0.44 -0.62 -170.97 -22.19 1.38 -1707.97
PAT 150.30 10.29 1360.64 150.30 10.29 1360.64 220.47 95.74 130.28
Equity 437.88 437.88 0.00 437.88 437.88 0.00 437.88 437.88 0.00
PBIDTM(%) 92.45 45.04 105.27 92.45 45.04 105.27 58.74 51.97 13.02

Shukra Pharmaceut. Share Price

42.48 0.79 (1.89%)
19-Aug-2026 13:54 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1175.00
Cipla 1417.80
Lupin 2219.90
Zydus Lifesciences 1106.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: